Stock Analysis
HCA Healthcare, Inc. (HCA) Stock Analysis
HCA Healthcare, Inc. (HCA) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
HCA Healthcare, Inc. (HCA) currently has an AIQ Score of 53/100, indicating a neutral setup. Sentiment is the strongest factor at 73/100. Quality is the weakest current factor at 43/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
HCA at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $426.94 |
| AIQ Score | 53/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Buy |
| Market Cap | $89.54B |
| P/E Ratio | 14.28 |
| Forward P/E | — |
| EPS | $7.62 |
| Revenue TTM | $20.23B |
| Dividend Yield | 0.00% |
| Beta | 1.11 |
| Volume | 1.32M |
| 52-week range | $353.99-$556.52 |
| RSI 14 | 48.34 |
| 50-Day SMA | $404.98 |
| 200-Day SMA | $450.72 |
| Analyst Price Target | $465.23 |
| Next Earnings | Oct 23, 2026 |
Create a free account to keep researching stocks
You have viewed 2 stock pages in the last 24 hours. Create a free account to keep researching current evidence.
HCA
OverviewHCA Stock Analysis Summary
HCA Healthcare, Inc. (HCA) currently has an AIQ Score of 53/100, indicating a neutral setup. Sentiment is the strongest factor at 73/100. Quality is the weakest current factor at 43/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, HCA has AIQ Score of 53/100 with Sentiment base of 73/100 and fading Quality at 43/100. Wait for component alignment before adding exposure.
Sentiment (73/100) leads while Quality (43/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 1.36% stock move · HCA classified in Medical - Care Facilities.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is HCA Bullish or Bearish Right Now?
HCA currently has a neutral overall setup. Sentiment is the strongest factor at 73/100, while Quality is weakest at 43/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Price is +5.42% above its 50-day SMA.
- - Analyst target implies +8.97% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (30 vs 8).
- - Risk Resilience is weak at 43/100.
- - Price is -5.28% below its 200-day SMA.
Current Consensus
HCA's Technical Analysis Consensus is currently Buy, with 30 buy, 7 neutral, and 8 sell votes. HCA's 14-day RSI is 48.34, which places the stock in a neutral momentum range. HCA's beta is 1.11, indicating market sensitivity broadly in line with the market.
What Changed in HCA?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the HCA Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
HCA Decision Framework
Public evidence layers, setup checks, and risk context for HCA Healthcare, Inc..
HCA Healthcare, Inc. (HCA) Stock Analysis
HCA Healthcare, Inc. has an AIQ Score of 53/100 in a Neutral regime. Sentiment is strongest at 73/100. Beta is 1.11, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | HCA is in a Neutral AIQ regime with score 53/100. |
| Signal Conflict | The primary conflict is that sentiment leads at 73/100 while quality lags at 43/100. |
| Factor Evidence | Momentum 54/100 · Value 67/100 · Quality 43/100 · Risk 43/100 · Sentiment 73/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Sentiment is the strongest factor at 73/100.
Momentum is 54/100 and RSI (14) is 48.3.
HCA is in a Neutral regime at 53/100.
Risk factor is 43/100 with beta 1.11 and annual volatility 30.75%.
Current conflict: sentiment leads at 73/100 while quality lags at 43/100.
HCA Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
HCA Fundamentals
HCA valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
HCA Technical Analysis
HCA technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
HCA Stock Catalysts
Track HCA earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
HCA Dividend Analysis
HCA dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
HCA Financial Data
HCA revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
HCA Risk Analysis
HCA volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
HCA Stock News
HCA stock news, market tone, recent headlines, and catalyst context.
HCA vs Healthcare Services / Managed Care Peers
Current peer cohort: HCA · HCAT · HIMS · HSIC · HUM. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| HCA Current stock | 53/100 | 67/100 | 54/100 | 43/100 | 0.28 | 30.75% | Current |
| HCAT Health Catalyst | 50/100 | 73/100 | 58/100 | 39/100 | -0.34 | 89.92% | HCA vs HCAT |
| HIMS Hims & Hers Health | 35/100 | 58/100 | 24/100 | 19/100 | -0.19 | 93.21% | HCA vs HIMS |
| HSIC Henry Schein | 56/100 | 65/100 | 60/100 | 66/100 | 1.03 | 25.76% | HCA vs HSIC |
| HUM Humana | 56/100 | 55/100 | 83/100 | 62/100 | 1.02 | 47.24% | HCA vs HUM |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts7 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching HCA
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for HCA
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
HCA Stock FAQ
What is HCA stock price today?
HCA Healthcare, Inc.'s current stock price is $426.94. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is HCA bullish or bearish right now?
HCA's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is HCA's market cap?
HCA's market cap is $89.54B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is HCA's current P/E ratio?
HCA's current P/E ratio is 14.28 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is HCA's RSI?
HCA's 14-day RSI is 48.34 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is HCA above its 50-day and 200-day moving averages?
HCA is 5.42% from its 50-day SMA and -5.28% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is HCA's next earnings date?
HCA's next earnings date is currently listed as Oct 23, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does HCA pay a dividend?
HCA's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.